Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company operates through the following segments: Diagnostic Imaging and Interventional Imaging. The Diagnostic Imaging segment includes MRI and X-Ray contrast media. The Interventional Imaging covers any invasive medical procedure whose purpose is to diagnose and treat a disease. The company was founded by André Guerbet in 1926 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
2,905
Frequently Asked Questions
What is Market Cap of Guerbet SA?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Guerbet SA market cap is $187.85M.